Target intelligence / Profile preview

REV3L antisense RNA 1 (REV3L-AS1)

Target
REV3L-AS1
Molecular classification
Other (long non-coding RNA / lncRNA)
01

Overview

REV3L antisense RNA 1 (REV3L-AS1) is a long non-coding RNA located antisense to the REV3L gene, which encodes the catalytic subunit of DNA polymerase zeta. The biological role of REV3L-AS1 has not been characterized in the literature, and it does not have documented involvement as a therapeutic target or disease biomarker. The majority of available research, both functional and translational, concerns the protein-coding REV3L gene and protein, which is essential for translesion DNA synthesis, chemoresistance, and maintenance of genome stability[1][2][3][5]. Note: If you are interested in the protein-coding gene (REV3L, DNA polymerase zeta catalytic subunit), there is extensive information available on its function, relevance in cancer chemoresistance, and potential as a drug target[1][2][3][4]. REV3L-AS1, as an lncRNA, currently lacks recognized biological function or clinical relevance in major databases and literature.

Other names
REV3L-AS1
02

Biological functions

Unknown, likely gene expression regulation (as antisense lncRNAs may regulate their sense gene partners, but this is not yet established for REV3L-AS1)
03

Disease associations

Other (no direct disease association for the antisense RNA is established; almost all literature links disease to the protein-coding gene REV3L[1][3][4][5])

Beyond the preview

Go deeper on REV3L antisense RNA 1 (REV3L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REV3L antisense RNA 1 (REV3L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call